Treatment and prognostic analysis of patients with leptomeningeal metastases from non‐small cell lung cancer

Publisher： John Wiley & Sons Inc

E-ISSN： 1759-7714|6|4|407-412

ISSN： 1759-7706

Source： Thoracic Cancer, Vol.6, Iss.4, 2015-07, pp. : 407-412

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Basic fibroblast growth factor shows prognostic impact on survival in operable non‐small cell lung cancer patients

By  

Thoracic Cancer, Vol. 6, Iss. 4, 2015-07 ,pp. : 450-457

John Wiley & Sons Inc

Access to resources Recommend Favorite

Survival analysis of patients with advanced non‐small cell lung cancer receiving tyrosine kinase inhibitor (TKI) treatment: A multi‐center retrospective study

By  

Thoracic Cancer, Vol. 9, Iss. 2, 2018-02 ,pp. : 278-283

John Wiley & Sons Inc

Access to resources Recommend Favorite

Self‐reported depression among patients with non‐small cell lung cancer

By  

Thoracic Cancer, Vol. 6, Iss. 3, 2015-05 ,pp. : 334-337

John Wiley & Sons Inc

Access to resources Recommend Favorite

Combination of platelet to lymphocyte ratio and neutrophil to lymphocyte ratio is a useful prognostic factor in advanced non‐small cell lung cancer patients

By  

Thoracic Cancer, Vol. 6, Iss. 3, 2015-05 ,pp. : 275-287

John Wiley & Sons Inc

Access to resources Recommend Favorite

Multicentric retrospective analysis of platinum‐pemetrexed regimens as first‐line therapy in non‐squamous non‐small cell lung cancer patients: A “snapshot” from clinical practice

By  

Thoracic Cancer, Vol. 9, Iss. 2, 2018-02 ,pp. : 241-252

John Wiley & Sons Inc

Access to resources Recommend Favorite